In this study we aimed at identifying whether T cells specific to mutant CALR enrich in the bone marrow after therapeutic cancer vaccinations, as homing of T cells to the tumor microenvironment is important to attain a response to cancer immune therapy (19, 27). The gene discussed is CALR; the disease is neoplasm.